Stockreport

Essential Pharma reaches agreement with AGC Biologics for late phase clinical manufacturing of its immunotherapy candidate for the treatment of high-risk neuroblastoma [Yahoo! Finance]

AGC INC UNSP/ADR  (ASGLY) 
PDF Egham, UK and Copenhagen, Denmark – 11 June, 2024 – Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access [Read more]